GLAS vs NAGE: stock comparison and AI forecast
Glass House Brands Inc. (GLAS) and Niagen Bioscience, Inc. (NAGE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GLAS Glass House Brands Inc.
- Market Cap
- $196M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NAGE Niagen Bioscience, Inc.
- Price
- $2.07 -50.6% · 6M
- Market Cap
- $164M
- P/E Ratio
- 14.8x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GLAS is 1.2 times larger than NAGE by market capitalization ($196M against $164M).
- NAGE turns 8.4% of its revenue into net income, against -17.8% for GLAS.
- GLAS carries 1.95 times debt per unit of equity, against 0.31 times for NAGE.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GLAS | NAGE |
|---|---|---|
| Market Cap | $196M | $164M |
| P/E Ratio | – | 14.78x |
| P/B Ratio | 2.65x | 1.97x |
| EPS | – | $0.14 |
| Book Value/Share | $0.78 | $1.05 |
| Revenue/Share | – | $1.55 |
Profitability & Margins
| Metric | GLAS | NAGE |
|---|---|---|
| ROE | -33.9% | 12.3% |
| ROA | -7.9% | 9.4% |
| ROIC | – | 5.2% |
| Gross Margin | – | 63.9% |
| Operating Margin | – | 3.9% |
| Net Margin | -17.8% | 8.4% |
| EBT Margin | – | 9.0% |
| Tax Rate | – | 7.4% |
Financial Health
| Metric | GLAS | NAGE |
|---|---|---|
| Current Ratio | 1.78x | 5.93x |
| Quick Ratio | 1.09x | 4.71x |
| D/E Ratio | 1.95x | 0.31x |
| Financial Leverage | 4.31x | 1.31x |
| Interest Coverage | -3.6x | 4086.0x |
| Working Capital | $30M | $83M |
Cash Flow
| Metric | GLAS | NAGE |
|---|---|---|
| Operating Cash Flow | – | $5M |
| OCF Growth YoY | – | -77.2% |
Operational Efficiency
| Metric | GLAS | NAGE |
|---|---|---|
| Asset Turnover | – | 1.13x |
| Receivables Turnover | – | 17.9x |
| Inventory Turnover | – | 2.1x |
| Fixed Assets Turnover | – | 100.6x |
| Days Sales Outstanding | – | 20 days |
| Days Inventory | – | 170 days |
| Payables Period | – | 95 days |
| Cash Conversion Cycle | – | 95 days |
Income Statement
| Metric | GLAS | NAGE |
|---|---|---|
| Total Revenue | – | $122M |
| Operating Income | – | $5M |
| Net Income | -$25M | $10M |
| R&D Expense | – | $6M |
| SG&A Expense | – | $41M |
| Cost of Goods Sold | – | $44M |
Dividend & Shareholder Information
| Metric | GLAS | NAGE |
|---|---|---|
| Shares Outstanding | 94M | 79M |
| Net Income Growth | – | -49.9% |
| EPS Growth | – | 0.0% |
GLAS vs NAGE: stock comparison and AI forecast
Which is bigger, GLAS or NAGE?
GLAS is 1.2 times larger than NAGE by market capitalization ($196M against $164M).
Which one does Intratio's AI model rank higher, GLAS or NAGE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.